We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA has unveiled enhanced warnings for opioid pain medications that will affect 141 generic and 87 innovative immediate-release opioid products, which account for roughly 90% of all prescription opioids. Read More
The FDA has slapped hair and skincare products maker Alikay Naturals with a warning letter that takes the company to task for the presence of lead in one of its products. Read More
Health insurer Anthem is suing Express Scripts in federal court for nearly $15 billion, claiming that the PBM has overcharged and is refusing to renegotiate future drug prices. Read More